2株柔嫩艾美耳球虫对5种抗球虫药的抗药性

选择130只21日龄雏鸡，研究了柔嫩艾美耳球虫（E.tenella)南京株和凤阳株对地克珠利（Diclazuril)、马杜霉毒（Maduramicin)、氯羟吡啶（Clopidol)、氯苯胍（Robenidine)和氨丙啉（Amprolium)的抗药性。试验鸡随机分成13组，其中每株球虫均设5个感染用药组，1个感染不用药组，另设1个不感染不用药组，每组10只鸡。以POAA，RLS，ROP，ACI作为指标。结果表明，2株柔嫩艾美耳球虫均对氨丙啉轻度抗药，对地克珠利敏感或轻度抗药，对氯羟吡啶中度抗药。对马杜霉和氯苯胍中度抗药或安全抗药。提示：目前在凤阳地区可合理地使用地克珠利和氨丙啉，对氯羟哟啶应慎用，对马杜霉素和氯苯胍须减少或暂停使用。     

柔嫩艾美耳球虫扬州分离株对8种抗球虫药的抗药性

将柔嫩艾美耳球虫(Eimeria tenella)扬州分离株感染14日龄苏禽黄羽肉鸡,设立8个用药组、1个感染不用药对照组和1个不感染不用药对照组,以相对卵囊产量、病变记分减少率、最适抗球虫百分数和抗球虫指数为指标对该虫株对盐霉素、马杜拉霉素、球痢灵、氯羟吡啶、氨丙啉、尼卡巴嗪、甲基三嗪酮、地克珠利等8种常用抗球虫药的抗药性进行了综合评定,分析了该地区球虫的抗药性及对策。结果表明,该虫株对甲基三嗪酮敏感,对氨丙啉具有中度抗药性,对盐霉素、马杜拉霉素、球痢灵、氯羟吡啶、尼卡巴嗪、地克珠利等其他6种药物具有完全抗药性。提示目前在扬州地区甲基三嗪酮抗球虫疗效最好,氨丙琳效果稍差,应合理使用,盐霉素等其他6种药物应慎用、减少或暂停使用。     

柔嫩艾美耳球虫果洛分离株的耐药性试验

雏鸡分组后人工感染果洛地区柔嫩艾美耳球虫分离株2.4×105个/只,分别采用地克珠利、氨丙啉、尼卡巴嗪、磺胺氯吡嗪钠、复方磺胺对甲氧嘧啶等5种常用抗球虫药进行治疗观察,以POAA、RLS、ROP、ACI作为评定指标.结果表明,柔嫩艾美耳球虫果洛分离株对氨丙啉、地克珠利高度敏感,对尼卡巴嗪、磺胺氯吡嗪钠均产生不同程度的耐...     

柔嫩艾美耳球虫秦皇岛和唐山分离株对7种抗球虫药的耐药性

选择360只14日龄雏鸡,随机分成18组,其中每个分离株均设7个感染用药组,1个感染不用药组,1个不感染不用药组,每组20只,以POAA、RLS、ROP、ACI作为指标.结果显示,除唐山株柔嫩艾美耳球虫仅对氨丙啉和尼卡巴嗪敏感外,秦皇岛株和唐山株对其他药物均产生不同程度的抗药性,其中对球敌均呈现完全抗药性.结果表明,目前在唐山地区可合理地使用氨丙啉和尼卡巴嗪,对其他药物在秦皇岛和唐山两地区须减少或暂停使用.     

秦皇岛株鸡柔嫩艾美耳球虫耐药谱变迁分析

试验选用14日龄健康雏鸡154只,随机分为5个感染药物组、1个阳性组和1个阴性组,每组22只。采用POAA、RLS、ROP和ACI综合评定QHD-08株柔嫩艾美耳球虫的耐药谱。结果显示,QHD-08株柔嫩艾美耳球虫对尼卡巴嗪呈现中度耐药,对克球粉、氨丙啉、马杜霉素和瑞冠球均呈现完全耐药;在2004-2008年期间,QHD株柔嫩艾美耳球虫对氨丙啉的耐药变迁结果为无耐药性→轻度耐药→完全耐药;对尼卡巴嗪的耐药性由2006年轻度耐药转变为2008年中度耐药,而克球粉、马杜霉素、氨丙啉和瑞冠球等4种抗球虫药的耐药性均从2006年的轻度(或中度)耐药转变为2008年的完全耐药。结果表明,QHD株柔嫩艾美耳球虫对常用抗球虫药物的耐药谱宽,且耐药率呈逐年递增的趋势。     

鸡球虫田间混合种和柔嫩艾美球虫单一种的抗药性试验

用上海某鸡场分离的球虫田间混合种及从其中分离纯化的4株柔嫩艾美球虫（Eimeria tenella)单一种对常用抗球虫药的抗药性进行检测，发现该球虫田间种对氯羟吡啶（clopidol)，马杜拉霉素（maduramicin)，莫能菌素（monensin), 氨丙啉（amprolium)4种抗球虫药已产生完全抗药性，对氯苯胍（robenidine)轻度抗药，对地克珠利（diclazuril)无抗药性，4株柔嫩艾美球虫单一种对氯羟吡啶，马杜拉霉素，莫能菌素，氨丙啉的抗药谱与该球虫田间混合种基本一致。     

柔嫩艾美球虫常州株对5种抗球虫药的抗药性分析

将柔嫩艾美耳球虫(E.tenella)常州分离株感染14日龄苏禽黄羽肉鸡,设立5个用药组、1个感染不用药对照组和1个不感染不用药对照组,以相对卵囊产量、病变记分减少率、最适抗球虫百分数和抗球虫指数为指标对该虫株对球虫宁、地克珠利、马杜霉素、磺胺氯吡嗪、癸氧喹酯5种常用抗球虫药的抗药性进行了综合评定,分析了该地区球虫的抗药性及用药对策。结果表明,该虫株对癸氧喹酯敏感,对球虫宁、地克珠利、马杜霉素、磺胺氯吡嗪具有完全抗药性,提示目前常州地区球虫抗药性非常严重,癸氧喹酯抗球虫疗效最好,其他药物应合理使用、应慎用、减少或暂停使用。     

5株柔嫩艾美耳球虫对4种抗球虫药的抗药性

选择260只19日龄雏鸡，随机分成26组，每组10只，研究柔嫩艾美耳球虫(E．tenella)南京株、凤阳株、扬州株、宣城株和蒙城株对地克珠利(Diclazuril)、马杜霉素(Maduramicin)、氯羟吡啶(C1opido1)、氯苯胍(Robenidine)的抗药性。每株球虫均设4个感染用药组、1个感染不用药组，另外设1个不感染不用药组。以POAA、RLS、ROP、ACI作为指标，判定5株球虫对4种药物的抗药性。结果表明凤阳株、扬州株和蒙城株分别仅对马杜霉素、氯苯胍、地克珠利敏感，南京株和宣城株对该4种药物均已产生不同程度的抗药性。提示目前在凤阳、扬州和蒙城地区可分别合理地使用马杜霉素、氯苯胍和地克珠利，对其它药物须减少或暂停使用。     

安徽3株柔嫩艾美耳球虫对5种抗球虫药的耐药性检测

采用鸡体试验法,以抗球虫指数、最适抗球虫活性百分率、病变记分减少率和相对卵囊产量4项指标综合判定,安徽庐江县、青阳县和肥西县3个地区鸡柔嫩艾美耳球虫对磺胺氯吡嗪钠、马杜拉霉素、氨丙啉、妥曲珠利、地克珠利的耐药性。结果显示,庐江株对氨丙啉和妥曲珠利敏感,对磺胺氯吡嗪钠和地克珠利完全耐药,对马杜拉霉素中度耐药;青阳株对地克珠利和妥曲珠利敏感,对磺胺氯吡嗪钠和马杜拉霉素完全耐药,对氨丙啉中度耐药;肥西株对磺胺氯吡嗪钠敏感,对妥曲珠利中度耐药,对地克珠利、马杜拉霉素和氨丙啉完全耐药。     

尼卡巴嗪对鸡柔嫩艾美耳球虫田间株的敏感性试验

以最适抗球虫活性百分率(POAA)、病变记分减少率(RLS)、相对卵囊产量(ROP)和抗球虫指数(ACI)为指标,检测了尼卡巴嗪对秦皇岛株和唐山株柔嫩艾美耳球虫的敏感性.结果表明,唐山株柔嫩艾美耳球虫对尼卡巴嗪无耐药性,秦皇岛株对其呈轻度耐药性.提示尼卡巴嗪在唐山和秦皇岛地区可以继续合理使用,但应控制用量和使用时间,以...     

巨型艾美耳球虫和柔嫩艾美耳球虫早熟株对8种抗球虫药的敏感试验

为检测巨型艾美耳球虫和柔嫩艾美耳球虫早熟株对常用抗球虫药的敏感性,选用地克珠利、氯苯胍、二硝托胺、癸氧喹酯、尼卡巴嗪、马杜米星、盐霉素和拉沙洛西等8种抗球虫药进行鸡体试验,通过抗球虫活性百分比（percent of optimum anticoccidial aetivity,POAA）、病变记分减少率（reduction of lesion scores,RLS）、相对卵囊产量（relative oocyst production,ROP）和抗球虫指数（anticoccidial index,ACI）4项指标进行综合评价。结果表明,巨型艾美耳球虫早熟株对8种药物敏感;柔嫩艾美耳球虫早熟株对盐霉素轻度敏感,对地克珠利、氯苯胍、二硝托胺、癸氧喹酯、尼卡巴嗪、马杜米星和拉沙洛西敏感。本研究结果可为对球虫早熟株疫苗的开发与应用提供实验依据。     

上海地区鸡球虫对6种抗球虫药的抗药程度研究

为了解上海地区的鸡球虫抗药性状况,作者采集了上海市9个区县10个鸡场的球虫,进行了对地克珠利（Diclazuril)、氯苯胍（Robenidine)、氯羟吡啶（Clopidol)、氨丙啉（Amprolium)、马杜拉霉素（Maduramicin)、莫能霉素（Monensin)的抗药性研究。试验设6个药物组和感染不用药、不感染不用药2个对照组,以抗球虫指数（ACI）、病变记分减少率（RLS）、相对卵囊产量（ROP）、最适抗球虫活性百分率（POAA）为试验指标,进行综合评定,其抗药程度分为无抗药性、轻度抗药性、中度抗药性、完全抗药性4个等级。结果显示来自10个鸡场的球虫中,对地克珠利有90％未产生抗药性,对氯苯胍有90％为无抗药性和轻度抗药,对驻杜拉霉素有50％为无抗药性和轻度抗药,对氯羟吡啶有80％达到完全抗药,对氨丙啉有90％达到中度和完全抗药,对莫能霉素则全部达到中度以上的抗药程度,作者认为目前在上海地区以放心地理合理使用地克珠利和氯苯胍,对马杜拉霉素要慎使用,对氯羟吡啶、氨丙啉、莫能霉素须减少或暂停使用。     

堆型艾美耳球虫早熟株对常用抗球虫药的敏感性测定

The study was aimed to explore the sensitivity of Eimeria acervulina （E.acervulina） precocious strain to some common anticoccidials (diclazuril, toltrazuril, sulfamonomethoxine, dinitolmide, decoquinate, nicarbazin, maduramicin, salinomycin and oxytetracycline). The sensitivity of E.acervulina precocious strain to 9 kinds anticoccidials was assessed by using 4 indices: anticoccidial activity percentage (POAA), reduction of lesion scores (RLS), relative oocyst production (ROP) and anticoccidial index (ACI). The results of these sensitivity trials indicated that the four indices POAA, RLS, ROP and ACI of groups toltrazuril, sulfamonomethoxine, dinitolmide, decoquinate, nicarbazin, salinomycin and oxytetracycline were all negative; the ROP index of diclazuril group was positive, the other three indices were negative. The ROP and ACI indices of maduramicin group were positive, the other two indices were negative. The results showed that the Eimeria acervulina precocious strain was sensitive to diclazuril, toltrazuril, sulfamonomethoxine, dinitolmide, decoquinate, nicarbazin, salinomycin and oxytetracycline, it was partly sensitive to maduramicin.     

A survey of sensitivity to anticoccidial drugs in 60 isolates of coccidia from broiler chickens in Brazil and Argentina

Coccidia were isolated from 90 broiler farms in 15 poultry-producing areas in Brazil and Argentina. Sixty isolates were tested for sensitivity to 7 anticoccidial drugs. The common species were: a) Eimeria tenella, 47 isolates; b) E. maxima, 49 isolates; c) E. acervulina, 44 isolates; d) E. mitis, 26 isolates; and e) E. brunetti, 12 isolates. Isolates were considered sensitive to drugs if intestinal lesion scores of medicated broilers were reduced by at least 50% compared with unmedicated infected broilers or if weight gain was at least 75% of that of uninfected birds in a 6-day laboratory test. According to lesion scores, there was evidence of resistance or seriously reduced sensitivity to monensin in 20 isolates, narasin in 29, salinomycin in 11, maduramicin in 1, clopidol in 36, amprolium in 40, and nicarbazin in 1. According to broiler weight gain, there was resistance to monensin in 36 isolates, narasin in 32, salinomycin in 28, maduramicin in 2, clopidol in 28, amprolium in 50, and nicarbazin in 4. These results suggested incomplete cross resistance of coccidia to polyether ionophorous drugs. The degree of resistance might be explained by previous patterns of use of these drugs.     

Sensitivity of field isolates of Eimeria tenella to anticoccidial drugs in the chicken

Thirty isolates of Eimeria tenella obtained from broiler and breeder farms were examined for their sensitivity to anticoccidial drugs. All were sensitive to robenidine, 28 were sensitive to methyl benzoquate, 25 to clopidol and 21 to nicarbazin. Most isolates were resistant or partly resistant to amprolium and dinitolmide.     

Drug-sensitivity of 99 isolates of coccidia from broiler farms

Coccidia were isolated from 99 broiler farms in 12 broiler-producing states and tested for sensitivity to contemporary anticoccidial drugs. The isolates usually comprised two or more species, including 92 Eimeria acervulina, 47 E. maxima, 28 E. tenella, and 10 E. brunetti. Based on intestinal-lesion-score reduction of 30% or more, 38% of isolates were resistant to monensin (110 ppm), 29% to salinomycin (60 ppm), 20% to nicarbazin (125 ppm), and 46% to amprolium + ethopabate (125 + 4 ppm). Isolates with 50% or greater reduction of lesion scores were considered sensitive. Thirty-three percent were sensitive to monensin, 53% to salinomycin, 67% to nicarbazin, and 39% to amprolium + ethopabate. Other isolates had intermediate response to drugs and were considered to have "reduced sensitivity." There was some evidence for incomplete cross resistance to the polyether, ionophorous products.